| II-065 Woojin Jung Predicting lung exposure of intramuscular niclosamide as an antiviral agent against COVID-19 using power-law-based pharmacokinetic modeling Wednesday 15:20-16:50 |
| II-065 Woojin Jung Predicting lung exposure of intramuscular niclosamide as an antiviral agent against COVID-19 using power-law-based pharmacokinetic modeling Wednesday 15:20-16:50 |